(19)
(11) EP 4 007 568 A1

(12)

(43) Date of publication:
08.06.2022 Bulletin 2022/23

(21) Application number: 20780922.9

(22) Date of filing: 31.07.2020
(51) International Patent Classification (IPC): 
A61K 9/50(2006.01)
A61P 7/02(2006.01)
A61K 31/4439(2006.01)
A61P 9/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4439; A61P 7/02; A61P 9/10; A61K 9/5078
(86) International application number:
PCT/EP2020/025352
(87) International publication number:
WO 2021/018414 (04.02.2021 Gazette 2021/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.08.2019 EP 19460039

(71) Applicant: Zaklady Farmaceutyczne Polpharma S.A.
83-200 Starogard Gdanski (PL)

(72) Inventors:
  • HRAKOVSKY, Julia
    80-862 Gdansk (PL)
  • PRZERADA, Szymon
    83-200 Starogard Gdanski (PL)
  • KACZMAREK, Mateusz
    63-400 Ostrow Wielkopolski (PL)
  • SKOCZEN, Przemyslaw
    83-010 Straszyn (PL)

(74) Representative: Kondrat, Mariusz 
Kondrat & Partners Al. Niepodleglosci 223/1
02-087 Warszawa
02-087 Warszawa (PL)

   


(54) PHARMACEUTICAL COMPOSITION COMPRISING DABIGATRAN ETEXILATE